Buprenorphine Tablet
Product Images NDC 0228-3153

6 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 0228-3153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure For Buprenorphine HCl, Usp Has The Molecular Formula C29 H41 No4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly Soluble In Water, Freely Soluble In Methanol, Soluble In Alcohol And Practically Insoluble In Cyclohexane. (Image Opava 1)

The Following Chemical Structure For Buprenorphine HCl, Usp Has The Molecular Formula C29 H41 No4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly Soluble In Water, Freely Soluble In Methanol, Soluble In Alcohol And Practically Insoluble In Cyclohexane. (Image Opava 1)
Chemical structure of Buprenorphine hydrochloride, depicting its molecular framework including hydroxyl, methoxy, and cyclopropyl groups.*
FDA Label Image

Tablets Debossed (Image Opava 2)

Tablets Debossed (Image Opava 2)
Buprenorphine 2 mg sublingual tablets packaging label from Actavis Pharma, Inc. The label includes product name, strength, dosage form, and instructions visible on a small white blister card with tablets. Packaging indicates medication is a prescription drug.*
FDA Label Image

Tablets Debossed (Image Opava 3)

Tablets Debossed (Image Opava 3)
Buprenorphine 2 mg sublingual tablet blister packaging. The image shows a small blister card containing one round tablet. The labeler is Actavis Pharma, Inc. Strength and dosage form are clearly indicated on the packaging.*
FDA Label Image

Image (Image Opava 4)

Image (Image Opava 4)
An instructional illustration showing a person placing a sublingual tablet under their tongue using their fingers. The open mouth highlights the placement area beneath the tongue for the tablet.*
FDA Label Image

1 (Image Opava 5)

1 (Image Opava 5)
Label for Buprenorphine Sublingual Tablets 2 mg by Actavis Pharma, Inc., showing a package of 30 tablets. The label includes dosing instructions, storage conditions, and a caution to dispense the medication guide with the product. Manufactured by Teva Czech Industries s.r.o. and labeled for Teva Pharmaceuticals, Parsippany, NJ.*
FDA Label Image

2 (Image Opava 6)

2 (Image Opava 6)
Label for Buprenorphine Sublingual Tablets 8 mg by Actavis Pharma, Inc., presented in a sublingual tablet form. The label includes dosing container instructions, storage conditions, lot/expiration information area, and directions to dispense the medication guide with the product. It states the package contains 30 tablets and highlights safety warnings regarding accidental ingestion by children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.